HostDx Sepsis in the Diagnosis and Prognosis of Emergency Department Patients with Suspected Infections (SEPSIS-SHIELD)

Grants and Contracts Details

StatusActive
Effective start/end date1/16/20 → 3/17/25

Funding

  • Inflammatix Incorporated: $89,650.00